Decisions can feel overwhelming, especially when you’re juggling pros and cons in your head. A classic list might seem ...

Boston Consulting Group Related stories BCG had a global revenue of about $12 billion in 2023. BCG is led by Christoph Schweizer, who has served as CEO since 2021, and Rich Lesser, the Global ...

How does the cost-effectiveness of treatments, particularly in relation to newer therapies, influence your recommendations for patients with BCG-unresponsive NMIBC? Are there specific tools or ...

BCG, however, anticipates this spending to increase in 2025. Yet, assuming that global counterparts will also keep up with increased spending, this may mean that in India, where supply often ...

India is emerging as a leader in artificial intelligence (AI) investment and adoption, according to the latest AI Radarton Consulting Group (BCG) report from Bos. This report reveals that 80% of ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time oncology review, expediting access to this potential treatment. The FDA has ...

According to the BCG report, India’s total trade and gross domestic product (GDP) will grow 6.4% annually between 2023 and 2033 propelled by “China+1” trade and imports to meet demand from a ...

ANI India will face over USD 14.6 bn in additional duties, if US imposes 20 per cent tariff: BCG Report The ASEAN region, alongside India, stands out as a major beneficiary of the ongoing geopolitical ...

Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG ...

Additionally, research aims to enhance the effectiveness of standard treatments, such as chemotherapy and BCG therapy, through new formulations or combination approaches. In addition, preclinical ...